ABVC (abvcpharma.com) Bozor qiymatining balans qiymatiga nisbati

ABVC BioPharma Inc. (ABVC) kompaniyasining rasmiy ramzlari

ABVC BioPharma (ABVC) qat'iy sinov protokollariga tayangan holda, depressiya va saratonga qarshi fitofarmatsevtika vositalarini ishlab chiqishda mustahkam obro'ga ega. Ushbu narxlar grafigi 2.61 darajasidagi ko'rsatkichlarni aks ettiradi. Biznes modeli ishlab chiqarish va sinovlarni autsorsing qilishga asoslangan bo'lib, bu jamoa uchun zavodlar bilan bog'liq kapital xarajatlarni bartaraf etadi va shu bilan birga yangi terapevtik yechimlarni ishlab chiqishda yuqori chaqqonlikni ta'minlaydi.

ABVC ABVC BioPharma, Inc: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 26.10.2026 oraligʻida

ABVC BioPharma Inc. (ABVC) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi ABVC BioPharma|ABVC - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati ABVC BioPharma Inc|ABVC - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati ABVC BioPharma|ABVC - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati abvcpharma.com|ABVC - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati ABVC BioPharma|ABVC - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati ABVC BioPharma Inc|ABVC - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar ABVC BioPharma Inc
Kompaniyaning dastlabki tahlili:ABVC BioPharma - ABVC
ABVC BioPharma Inc original mahsuloti

Bozor qiymatining buxgalteriya qiymatiga nisbati aksiyalar narxining kompaniyaning sof aktivlariga nisbatan premiumi yoki diskontini o'lchaydi. Tadqiqotchilarining intellektual kapitaliga tayanadigan ABVC BioPharma uchun ushbu metrika uning klinik loyihalari potensialining bozor bahosini aks ettiradi. Balans hisobotiga nisbatan bozor kapitalizatsiyasi dinamikasidagi 2.61 ning joriy qiymati biznesning qanchalik hadda haddan tashqari sotib olingani yoki past baholanganini ko'rsatadi. Past nisbat mustahkam xavfsizlik zaxirasi haqida signal beradi; biroq, yakuniy xulosa chiqarish uchun qarz yuklamasining majburiy tahlili talab etiladi.

Asosiy raqobatchilar

HLN (Haleon plc) - Bozor kapitallashuvining balans qiymatiga nisbati|KVUE (kenvue.com) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Oramed Pharmaceuticals (ORMP) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati enterabio.com (ENTX)|Bozor kapitallashuvining balans qiymatiga nisbati HYFT (MindWalk Holdings Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati Cumberland Pharmaceuticals Inc CPIX|QNTM - Bozor kapitallashuvining balans qiymatiga nisbati|FibroGen Corporation (FGEN) - Bozor qiymatining balans qiymatiga nisbati|Telomir Pharmaceuticals (TELO) - Kapitallashuvning sof aktivlarga nisbati|Rani Therapeutics Holdings, Inc. (RANI) - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SNYR|Kapitallashuvning sof aktivlarga nisbati Rallybio Corp. (RLYB)|Lexaria Bioscience (LEXX) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Pulmatrix Corporation (PULM)|Bozor kapitallashuvining balans qiymatiga nisbati Pheton Holdings PTHL|Bozor qiymatining balans qiymatiga nisbati Aptorum Group Ltd APM|Bozor kapitallashuvining balans qiymatiga nisbati LYRA (Lyra Therapeutics)|IBO: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati TNFA|YCBD (cbdMD) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati PainReform Ltd. PRFX|Sof aktivlarga nisbatan bozor kapitallashuvi Auris Medical|Lipella Pharmaceuticals, Inc. (LIPO) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati OptiNose Inc (OPTN)|Bozor kapitallashuvining balans qiymatiga nisbati PIRS (Pieris)|Procaps Group Corp - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Petros Pharmaceuticals (PTPI)|QLI: Balans qiymatiga nisbatan bozor qiymati|SLRN (ACELYRIN) - Bozor qiymatining balans qiymatiga nisbati|TFF Pharmaceuticals Inc. (TFFP) - Kapitallashuvning sof aktivlarga nisbati